Professional Documents
Culture Documents
— means study of
— body of knowledge
DRUGS PHARMACODYNAMICS
• any substances that bring about a change in biologic function its • study of the mechanism of action
chemical actions • study of biologic activity that a drug has on a living system
• may be synthesized within the body (ex: hormones) or may be • what does the drug do it to the body
chemicals not synthesized in the body (ex: xenobiotics)
• can cause a change in physiologic activities PHARMACOKINETICS
• often associated with addictive, narcotic or mind-altering substances • deals with the magnitude & time course of drug effects
– an unfortunate negative connotation that tends to bias • εxplains the aspects of drug action through absorption,
opinion against any form of chemical therapy distribution, metabolism & excretion
A à absorption
MEDICINE D à distribution
• a chemical preparation which usually but not necessarily contains one M à metabolism
or more drugs, administered with the intention of producing a E à excretion
therapeutic effect
• many substances such as insulin/thyroxine, are endogenous PHARMACOGENOMICS
hormones but are also drugs when they are administered • relationship of the individual’s genetic makeup to his or her
intentionally response to a specific drugs
DRUG ABUSE GENERAL PRINCIPLES OF PHARMACOLOGY
— use of illegal drugs/the misuse of prescription or over-the- Pharmacodynamics: Mechanism of Drug Action
counter drugs for at least a year with negative consequences Pharmacodynamics in Greek:
— ex: potent painkillers
“Pharmakon” à drug
“Dynamics” à action/power
“it covers all the aspects relating to what drug does to the body”
I (drugs with no Ex: Cocaine/Coke/Crack, Heroin,
therapeutic use) Ecstasy/XTC/MDMA
DRUG-RECEPTOR INTERACTION
• drug
• receptor (site of attachment)
II (dangerous • drug-receptor complex
Ex: Methamphetamine (used for people with ADHD)
drugs) • pharmacologic action/effect/response
GENERIC DRUGS DRUG + RECEPTORàDRUG-RECEPTOR COMPLEX =
• a pharmaceutical product, usually intended to be PHARMACOLOGIC ACTION
interchangeable with an innovator product that is RECEPTOR
manufactured without a license from the innovator company & • biologic partners for drug action
marketed after the expiry date of the patent of other exclusive • structures involved in physiologic regulation
rights • ex: cells, enzymes, nucleic acids
ORPHAN DRUGS Classification:
• have been discovered but not financially viable 1. ION-CHANNEL-LINKED RECEPTOR
• considered to be effective a. Voltage- Gated Ion Channels
⇒ Na+, K+, Ca++, H+, Cl-
OVER-THE-COUNTER DRUGS
• available without prescription for self-treatment of a variety of
complaints
• safe when taken or directed there several problems with its use:
1. Mark signs & symptoms of an underlying
disease, making diagnosis difficult
2. Drug interaction & interfere with
drug therapy
3. Overdosing
LABELS OF A DRUG PACKAGE:
a. Storage information
b. Quantity (amount of drugs in a package)
c. Prescription Status
d. Administration b. Ligand-Gated Ion Channels
e. Manufacturer ⇒ Nicotinic receptor
f. Dose/Content (in every tablet)
g. Brand Name (given by the manufacturer) 2. G PROTEIN-LINKED RECEPTOR
h. Generic Name (chemical name of the drug listed in the National — metabotropic receptor
Formulary) — target for non antimicrobial prescription drugs
POISONS — maintenance drugs
• drugs that have almost exclusively harmful effects
TOXINS
• poisons of biologic origin
“PHARMAKON”
— means “poison” in classic Greek
— means “drug” in modern Greek
“LOGIA” 3. ENZYME-LINKED RECEPTOR
KMD| PHARMACOLOGY 2016
— site of attachment for neurotopic peptides growth hormones o have full affinity towards the receptor but intrinsic
— catalytic sites activity is 0 to -1
— cytoplasmic site of the receptor b. ANTAGONISTS
4. INTRACELLULAR RECEPTOR • drug that decrease or oppose the action of another
— sites of attachment within the cells drug/endogenous ligand
• no intrinsic activity
DRUG BINDING FORCES • also known as “BLOCKER”
• drugs interact with receptor by means of chemical forces or bonds • ex: methyldopa = considered as A1 blocker (stops the increase of
• 3 major types: Covalent, Electrostatic & Hydrophobic BP; considered to be as antihypertensive)
a. COVALENT
— very strong & not reversible under biologic conditions BETA BLOCKER à ANTIHYPERTENSIVE “OLOL”
— ex: covalent bon formed between acetyl group of ASA & 1. Nebivolol
cyclooxygenase (enzyme target in platelets) 2. Metoporol
3. Esmolol
ASPIRIN 4. Atenolol
à analgesic 5. Betaxolol
à antipyretic 6. Sotalol
à anticoagulant 7. Propanolol
b. ELECTROSTATIC
— weaker a. CARDIOSELECTIVE
c. HYDROPHOBIC o only targets the B1 receptor
— quite weak & important in interaction of highly lipid-soluble drugs o will not affect the RR of the patient
B - betaxolol
STRUCTURE-ACTIVITY RELATIONSHIP E - esmolol
• structures of a drug molecules are identified in order to determine A - atenolol
their influence on pharmacologic activity M - metoporol
• presence of functional groups b. NONCARDIOSELECTIVE
• ex: Caffeine (1,3,7-trimethylxanthine) ß CNS stimulant; ^HR, o can target both B1 & B2 receptors
^RR, release of EPI *nitrogen causes the adverse effects of o all other OLOLS
coffee
DRUG INTERACTION
— when one drug affect the pharmacological response of a
second drug given at the same time
— 3 major drug interactions:
• DRUG-DRUG INTERACTION à ex: Kremil-S
• DRUG-FOOD INTERACTION
• DRUG-DISEASE INTERACTION
DRUG-DRUG INTERACTION IS DUE TO:
• Pharmacokinetic effects
• Pharmacodynamic effects
DOSE-RESPONSE RELATIONSHIP — Increase drug effects Consequences of Drug
• Threshold concentration — Decrease drug effects Interaction:
• Ceiling Effect — Desired consequences
• Agonists — Adverse/Undesired effects
• Antagonists
DRUG-FOOD INTERACTION
ΟCCUPATION THERAPY: — best absorbed when there is food in the stomach
a. AGONISTS ex: Antibiotics, Anti-fungal antibiotics (requires a fatty meal), Pomelo
• drugs that binds to & activate the receptor, which
directly/indirectly brings about the effect POMELO (Citrus Grandis)
• ex: Alpha, Beta receptors — enzyme induction; potent enzyme inducer
— promotes the production of CYP450 enzyme (helps metabolize
drugs)
— English name: Grapefruit
*all drug interactions are not harmful*
KREMIL-S
— active ingredients: Aluminum Hydroxide (Al(OH)2),
Magnesium Hydroxide (Mg (OH)2)& Simethicone
— adverse effects:
i. FULL AGONIST
—
can cause maximum response to agonist
—
if a drug binds to a receptor and produced a maximal biologic
response that mimics the response to endogenous substance
ii. PARTIAL AGONIST
o have effects greater than or but less that of a full
agonists
o have less effects compare to full agonists
o in the presence of full agonist will act as an
antagonists
iii. INVERSE AGONIST Simethicone
o drug that binds to a receptor & produce an opposite — base + acid = neutralization reaction
effect — cancels out the burping
KMD| PHARMACOLOGY 2016
1. Heat is given off; exothermic
effects of
reaction R – RIFAMPICIN (orange/red color of body fluidsàurine, saliva, sweat,
neutralization
2. Formation of salts tears)
reaction
3. Release of oxygen I – ISONIAZID (peripheral neuritisàtingling sensation of finger tips)
= bubble formation = burp P – PYRAZINAMIDE (liver toxicity)
E – ETHAMBUTOL (optic neuritisàtingling sensation of eyes)
S– STREPTOMYCIN (deaf, nephric toxic)
DRUG ABSORPTION INTERACTION
*Isoniazid: Counterfeit of Vit. B6 (antidote for neurosis/neurotic
1. GI pH (Gastrointestinal)
)* BRAND NAME: Fixcom4 (RIPE; 6mos) & FIXCOM3 (RIE; 2mos)
ex: Cimetidine (increases pH) to Ketaconazole (weak acid drug)
MINIMUM DURATION: 6mos to 1yr
LINEZOLID
— super antibiotic
— administered for not TB patients who takes TB medication
— very toxic
AGE
1. Pediatric Patients
— 0-18yrs old
ex: Chloramphenicol (0-1yrs = Gray baby syndrome)
à antibacterial/antibiotic
à tx for typhoid fever (caused by salmonella typhi)
2. Complexation 2. Geriatric Patients
ROUTES OF ABSORPTION
1. Oral * without alcohol dehydrogenaseàinfinitely drunk or drunk forever*
2. Inhilation
3. Parental (IV, intramuscular, Subcutaneous)
3 PHASES OF ALCOHOL INTOXICATION:
4. Topical
I à drunk (euphoria, slurd speech, respiratory depression, pass out)
II à hangover
DISTRIBUTION
III à recover
— movement of the drug throughout the body
*alcohol dissolves B vitamins*
3 pathways:
DIET
1. First Pass effect – movement of drug to the liverà — affects metabolism
metabolism à eliminated — HOW?
2. Protein Binding – storage/binding of drug to protein ex: WARFARIN
a. Acidic Drugs à binds to albumin; does nothing • blood thinner/anti-coagulant
b. Basic Drugs à binds to α-glycoprotein • overdose = hemorrhage
3. Receptor • not allowed during administration: leafy green vegetables
(contains Vit. Kàcontains clotting factors such as 9,10,7 & 2)
METABOLISM • leafy green vegetables will cancel the effects of warfarin
A. Phase I Metabolic Reaction
• “functionalization reactions” ELIMINATION
• reduction, oxidation, hydrolysis • Major Organs
B. Phase II Metabolic Reaction 1. Liver
• “conjugation reactions” 2. Kidneys – major route
• sulfate conjugation, amino acid conjugation, glutathione • Other Organs
reaction, glucuronic acid conjugation, acetylation, methylation 1. Skin
Factors affecting metabolism: 2. Lacrimal fluid
3. Sweat
4. Expired Air
1. Genetics
5. Saliva
2. Age
3. Sex
4.
5.
Enzyme Induction – promotes metabolism
Enzyme Inhibition – promotes toxicity
ADRENERGIC AGONISTS
6. Diet – affect metabolism
Classification of Adrenergic Receptors:
DRUG: Isoniazid • Alpha 1
— tx for 3rd world disease (tuberculosis) • Alpha 2
— important in genetic factor metabolism • Beta
— metabolized through acetylation & methylation (exaggerated § Beta 1
neuritis) § Beta 2
KMD| PHARMACOLOGY 2016
§ Beta 3 § stimulate Alpha 1 receptors in the
• Dopamine brain
§ D1 § stimulates the blood brain barrier &
§ D2 centrally active adrenergic agonists
§ D3
§ D4 ENDOGENOUS CATECHOLAMINES: Dopamine
§ D5
7. Cardiovascular Effects
Classification of Adrenergic Agonists:
— D1– dilate renal, celiac, hepatic & mesenteric
A. DIRECT ACTING vasculature
— drugs that bind directly to the adrenergic receptor & — Fenoldopam à decrease BP, increase in renal blood
produces effects flow (Drug that decrease BP)
B. INDIRECT ACTING 8. Other Effects
— drugs that increases the amount of Norepinephrine — Nausea & Vomiting
& Epinephrine to stimulate the adrenergic receptors § stimulate medullary chemoreceptor
C. MIXED trigger zone
— can do both (Direct & Indirect acting) — D2 à dopamine binds to lactotrope cells in the
anterior pituitary gland
ENDOGENOUS CATECHOLAMINES (EP, NE & DOPAMINE): § inhibits the release of prolactin (a
NOREPINEPHRINE & EPINEPHRINE have effects on the ff à hormone that stimulates the breast
milk production)
1. Vascular Effects
— when norepinephrine binds to alpha receptors Sir Jace’s explanation: Dopamine also binds to medullary chemoreceptor
à BP, bradycardia, does not affect the heart rate trigger zone (responsible for the stimulation of gag reflex; over stimulation
— causes vasoconstriction = VOMITING)
Sir Jace’s explanation: when norepinephrine binds to an alpha receptors Bromcriptine
this will cause an increase in blood pressure due to vasoconstriction. Does • Dopaminergic agonist
not cause an increase in the heart rate. The NE’s effect is only the on the • treatment for female infertility
blood pressure & not with the heart rate. Contrary, it will cause the slowing • control excessive secretion of growth hormones which are
down of heart rate. associated with adenomas
• stimulate growth hormone release
2. Cardiac Effects
— NE & EP stimulate B1 receptors ALPHA ADRENERGIC RECEPTOR AGONISTS
— increase in HR • Phenylephrine & Methoxamine
— increase rate of force development & subsequent — selective action on Alpha-I adrenergic receptor
relaxation is accentuated — contraction of vascular smooth muscle
— increase BP; bradycardia
Sir Jace’s explanation: both NE & EP will stimulate the B1 receptors (main • Phenylpropanolamine
target is only the heart). Heart will increase the rate of force development & — OTC cold remedy
subsequent relaxation is accentuated. Therefore, there’s an increase in — increase risk for hemorrhagic stroke in women
heart rate. • Midodrine
— synthetic; selective alpha I adrenergic agonist
— vasoconstriction
3. Non-vascular Smooth Muscles — treatment for postural hypotension
— Alpha 1 à causes smooth muscle contraction • Clonidine, Guanabenz, Guanfacine, Methyldopa (Anti-
— Alpha 2 à causes smooth muscle relaxation hypertensive medications)
— enters CNS
Sir Jace’s explanation: Alpha 1 receptors will cause smooth muscle — stimulate selectively alpha 2 adrenergic receptors
contraction. When the smooth muscle contracts it generally stops the exit — centrally acting in the nucleus tractus solitaries of
of the following: urine & feces. For alpha 1 receptors, NE & EP will the brainstem
bind to alpha 1 receptors it will contract the urinary & rectal — moderate decrease in BP
sphincter causing smooth muscle contraction. For beta 2 receptors, — reduce venous return, heart rate, cardiac output
this will affect the lungs causing bronchodilation. • Methyldopa
— vasoconstrictor in local anesthetics
4. Salivary glands • Clonidine
— NE & EPI bind to secretory cells (a & B)
— first used as a nasal decongestant
— Alpha 1 stimulation on myoepithelial cells
— decrease blood pressure
- contract secretory acinar units
— xerostomia ß adverse effect
§ water & electrolyte secretion — *when given to addicts in withdrawal: blocks nausea
— Beta 2 receptors stimulate production of amylase & vomiting, sweating, diarrhea
(an enzyme that breaks down the starch particulary
• Oxymetazoline, Tetrahydrozoline, Xylometazoline
on alpha 1,4 glycosidic bond)
— stimulate alpha 2 adrenergic receptors
5. Metabolic Response
— contraction of smooth muscles in blood vessels
— glycogenolysis
— used as nasal decongestant
— increase in glucagon secretion
• Brimonidine & Apraclonidine
— Beta 3 – lipolysis; increase in free fatty acids
— newer alpha 2 agonists
— decrease intra-ocular pressure in patients with
Sir Jace’s explanation: whenever NE & EPI binds to alpha receptors & causes
glaucoma
glycogenolysis (breakdown of glycogen to its glucose form & undergoes
Kreb’s Cycle causing the conversion of glucose to energy in the form of ATP)
BETA ADRENERGIC RECEPTOR AGONISTS
• cardiac & vascular effects
6. CNS Effects • effects on bronchial smooth muscles
— Ephedrine, Amphetamine • metabolic effects
KMD| PHARMACOLOGY 2016
• nervousness
ISOPROTERENOL • excitability
• Cardiac & Vascular Effects • insomnia
— decreases diastolic BP by Beta 2 receptor-mediated • dizziness
vasodilation • tremors
— increase in systolic BP from increase CO caused by • xerostomia
stimulation of Beta I receptors • sexual dysfunction
— increase in heart rate due to stimulation of Beta I
receptors in the pace maker cells
• Effects on Bronchial Smooth muscle
— relaxes bronchioles, prevents bronchoconstriction
— non selective
— development of tolerance
• Metabolic & Other Effects
— stimulates glycogenolysis & gluconeogenolysis in
the liver
— not as effective as epinephrine
— causes CNS excitation
DOBUTAMINE
• synthetic dopamine
• no effect on dopamine receptors
• Alpha I receptor inhibition
• increase myocardial contractility, CO, heart rate
• inotropic effect by stimulation of beta I receptors
• for short-term treatment of acute myocardial insufficiency
from CHF, MI, surgery
SELECTIVE BETA 2 ADRENERGIC RECEPTOR AGONIST
METAPROTERENOL, TERBUTALINE, ALBUTEROL, LEVALBUTEROL,
PIRBUTEROL, SALMETEROL
• relax bronchial & uterine muscles
• decrease airway resistance
• inhaled drugs
RITODRINE
• uterine relaxant (tocolytic)
• short-term management for labor
• withdrawn from the market
MIXED ACTING ADRENERGIC AGONISTS
EPHEDRINE
• causes the release of NT – Epi & NE
• directly stimulates alpha & beta receptors
AMPHETAMINE, DEXTROAMPHETAMINE, METHAMPHETAMINE
• CNS active, indirect
• causes alertness, relief of fatigue, enhanced athletic
performance, euphoria
GENERAL THERAPEUTIC USES
— local vasoconstriction
— treatment of hypotension & shock
— ‘bronchodilation
— uterine relaxation
— ophthalmic uses
— treat allergic states
— CNS stimulation
— treat hypertension
ADVERSE EFFECTS
Cardiac Disturbances
• MI
• heart attack
• arrhythmias
• ventricular fibrillation
• hypertensive crisis
• rebound hypertension
CNS Reactions
KMD| PHARMACOLOGY 2016
ADRENERGIC ANTAGONISTS
Alpha 1 Adrenergic Receptor Antagonists
• Prazosin
• Terazosin
• Doxazosin
Effects:
— dilates arterioles & veins
• hypotension
— reduce cardiac output
— reduce renin release
THERAPEUTIC USES:
— alleviate signs & symptoms of CHF
• increases survival rate of patients
— treat benign prostatic hyperplasia (BPH)
• doxazosin & terazosin are preferred
Benign Prostatic Hyperplasia à an enlarged prostate gland; noncancerous
increase in the size of prostate.
THERAPEUTIC DOSES
— Prazosin à more than once (2-3x a day)
— Terazosin à once a day
— Doxazosin à once a day
ADVERSE EFFECTS:
— first-dose syncope à best describe by dizziness or fainting
— hypotension
— IFIS (Inoperable Floppy Iris Syndrome)
Sir Jace’s explanation: Syncope is best described by dizziness & fainting
because Prazosin, Terazosin & Doxazosin causes the lowering of BP.
ALFUZOSIN
— prostate-selective
— less likely to cause syncope
— once-a-day dose
— used to treat BPH
Sir Jace’s explanation: Alfuzosin is prostate-selective although this one can
cause the lowering of BP. Alfuzosin is used to treat BPH because its activity
lies mainly with its prostate active agent.
TAMSULOSIN
— treatment for BPH
— less likely to cause orthostatic hypotension & syncope
— Adverse Effects: stuffiness & skin rash
Sir Jace’s explanation: Tamsulosin was developed after Alfuzosin & its now
the drug of choice treating BPH.
NON-SELECTIVE ALPHA ADRENERGIC RECEPTOR
1. IMIDAZOLINES
A. Phentolamine
— antagonists to alpha 1 & 2 receptors
— cholinomimetic
— blocks serotonin
— cause hypotension, reflex tachycardia,
myocardial ischemia & cardiac arrest
— depressant
Uses: control pre-operative BP, management of
phaeochromocytoma, used in clonidine withdrawal, reversal of
soft tissue numbness after administration with local
anesthetics
Sir Jace’s explanation: Phentolamine is an antagonist to both alpha 1 & 2
receptors & at the same time this one will block Serotonin (responsible for
sense of well being). Phentolamine is a depressant & at the same it will
KMD| PHARMACOLOGY 2016
cause hypotension, myocardial ischemia & cardiac arrest. Phentolamine is
injected to patients after surgery to restore sensation. 3. Metabolic Effects
— antagonize beta receptors, hypoglycemia may occur
2. BETA-HALOALKYLAMINES — increase triglyceride concentration
A. PHENOXYBENZAMINE Sir Jace’s explanation: Beta blockers will cause hypoglycemia. When beta
— blocks alpha adrenergic receptors receptors are stimulated includes the effects of glycogenolysis. So that
— inhibits response to histamine, ACh, serotonin means, there’s a breakdown of glycogen to form glucose (WHEN IT IS
— used for pheochromocytoma, relaxes urinary STIMULATED). However, if it is blocked, glycogenolysis is also blocked
sphincter resulting to low blood sugar.
Adverse Effects: NE & EP reuptake, increases cardiac
excitability, contractility rate & cardiac output, orthostatic 4. Ocular Effects
hypotension, hypovolemia — reduce intra-ocular pressure in patients with
glaucoma
Sir Jace’s explanation: Phenoxybenzamine blocks alpha receptors & inhibits — reduce production of aqueous human in the eyes
response to histamine, ACh & serotonin; that means it will not response to
any sort of inflammation, movement & causes depression. Sir Jace’s explanation: Patients with glaucoma (a condition that happens to
your eyes. The optic nerve is stuck between the eye socket resulting to fluid
build up. The fluid build up is due to the increase production of the aqueous
BETA ADRENERGIC RECEPTOR ANTAGONISTS humour. Once the aqueous humour accumulates, it will increase the
à B1, B2, B3 diameter of the eyes & eventually resulting to permanent blindness.
Effects: effects on the CVS, effects on smooth muscles (bronchial & uterine 5. CNS Effects
muscles), gastrointestinal effects, metabolic effects, ocular effects & CNS — treat migraine headache, tremor associated with
effects anxiety
PROPRANOLOL à drug used to treat stage freight &
1. Effects on the CVS white coat syndrome
— decreases the rate & force of myocardial contraction
— blocks beta receptors in Sinoatrial node, THERAPEUTIC USES OF BETA BLOCKERS
Atrioventricular Node, Purkinje system § Hypertension
— no effect on normotensive patients § Ischemic heart disease
— used to treat angina pectoris § Post myocardial infarction
— reduce plasma renin contraction § Congestive heart failure
§ Treat arrhythmias
2 mechanisms in increase BP ADVERSE EFFECTS:
a. Baroreceptors à responsible in increasing BP
b. Renin Angiotensin System (RAS) à found in kidney I. HEART
• withdrawal can result to angina pectoris, myocardial
RENIN êRENIN infarction, sudden death
II. SMOOTH MUSCLES
• reduce adrenergic response to EP
• reduce adrenergic vasodilator response of the
vasculature to EP
Sir Jace’s explanation: Beta blockers will reduce adrenergic response to
ANGIOTENSIN II êANGIOTENSIN II Epinephrine. When a patients has asthma, it should be a Cardioselective
(Potent Vasoconstrictor) = Decrease in BP Beta Blocker so that the effects of beta blocker is exclusively for the heart &
= Increase in BP the BP. If it is Noncardioselective it will affect the bronchial muscles.
Sir Jace’s explanation: If you are going to stimulate B1 receptor there’s an III. METABOLIC EFFECTS
increase in Heart Rate but these are Beta Adrenergic Antagonist it will • hypoglycemia
decrease the heart rate & myocardial contraction & at the same time it will IV. CNS EFFECTS
block your beta receptors in SA node, AV node & Purkinje System (Pace • CNS depression, weakness, fatigue
Maker of heart that are responsible for the Lub-Dub of the heart). Beta • sleep disturbances, insomnia, nightmares
blockers do not have any effects on patients that have normal blood • hallucinations, dizziness, depression of mood
pressure. Used to treat angina pectoris (Chest pain). They are two
mechanisms by which your BP increase: Baroreceptors (responsible in
increasing the BP) but if Baroreceptors are not enough, Renin Angiotensin DRUGS WITH COMBINED EFFECTS:
System (RAS). Renin is found in kidneys which will eventually converted to
a substance called Angiotensin II (potent vasoconstrictor) thus LABETALOL
narrowing the blood vessels which will cause an increase in BP. Beta — administered through IV
blockers will reduce renin concentration in the body that means that lesser — decreases peripheral resistance & BP
the renin present, the lesser the angiotensin, the lesser vasoconstricting — vasodilator
effects therefore resulting to the lowering of BP. — used as long-term treatment of hypertension
CARVEDILOL
2. Effects on Smooth muscles — anti-hypertensive
— prevent sympathetic stimulation of bronchial — decreases morbidity & mortality associated with CHF
smooth muscles (Congestive Heart Failure)
— contraindicated in patients with bronchial — used in treating heart failure
disorders: Asthma & Emphysema
Sir Jace’s explanation: Effects on smooth muscles, first, it has the ability to
prevent sympathetic stimulation of the bronchial muscles. When there’s
sympathetic stimulation of the bronchioles resulting to dilation of the
bronchioles to allow oxygen. Beta blocker will prevent sympathetic
stimulation therefore causing bronchoconstriction.
KMD| PHARMACOLOGY 2016
Mechanism of action:
• Low doses of ACh à activates muscarinic
• High doses of ACh à activates nicotinic
MUSCARINIC RECEPTOR
M3
M1 M2 M4 M5
|
| | | |
SMOOTH
CNS HEART CNS CNS
MUSCLE
NICOTINIC RECEPTOR
N1/Nm N2/Nn
| |
Neuromuscular Autonomic ganglia,
Junction CNS, adrenal medulla
PHARMACOLOGIC EFFECTS:
§ PERIPHERAL MUSCARINIC EFFECTS
• EYE à miosis, decrease intra-ocular pressure
• HEART à decrease in heart rate
• VASCULAR SMOOTH MUSCLE à vasodilation,
decrease in BP
• BRONCHIAL SMOOTH MUSCLE à
bronchoconstriction
• GI SMOOTH MUSCLE à enhance motility & relax
sphincter muscles (urinary & rectal sphincter)
• SECRETORY GLANDS à stimulates the secretion of
saliva, lacrimal & bronchia
• URINARY TRACT à decreases bladder capacity
§ PERIPHERAL NICOTINIC EFFECTS
• N1 à Ganglia (high doses)
• N2 à CNS (low doses)
CHOLINERGIC DRUGS § CNS EFFECTS
• affects central regulation of physiologic functions
• influence cognition & emotion
— agents that mimic the action of endogenous NT à ACh
— also known as cholinomimetic agents or ANTICHOLINESTERASES
parasympathomimetic agents — drugs that stimulate cholinergic transmission by
— receptors: Nicotinic & Muscarinic receptors inhibiting the enzyme acetylcholinesterase
— reversible = edrophonium, neostrigmine, physostigmine
CLASSIFICATION: — irreversible = organophosphates
1. Choline Esters Sir Jace’s explanation: Anticholinesterase are agents that will inhibit or
— synthetic congeners of ACh destroy the presence of an enzyme called acetylcholinesterase.
— Metacholine, Carbachol, Bethanecol
2. Alkaloids & Congeners REVERSIBLE
A. PHYSOSTIGMINE
a. Muscarine (from Amanita Muscarina) • also known as eserine
— rapid onset of action of parasympathetic stimulation • Calabar Bean (Physostigma Venenosum)
b. Pilocarpine (Pilocarpous Jaborandi)
• treatment for glaucoma
c. Cevimeline
B. NEOSTIGMINE
d. Arecoline (Areca Catechu)
• derivative of physostigmine
e. Nicotine (Nicotiana Tabacum)
• treatment for Myasthenia Gravis (an autoimmune
disease)
Sir Jace’s explanation: Alkaloids are secondary metabolites in plants that
Symptoms: looping eyelids
can be used as drugs.
Treatment: neostigmine
Sir Jace’s explanation: When acetylcholinesterase is destroyed, it will still
MECHANISM OF ACTION
allow the production or reproduction of acetylcholinesterase afterwards.
1. Direct Acting
Reversible, these are drugs which will inhibit acetylcholinesterase.
— drug directly binds to nicotinic & muscarinic receptors
2. Indirect-Acting
IRREVERSIBLE
— drug induce the release of cholinergic NT to bind to
A. ORGANOPHOSPHATES
nicotinic & muscarinic receptors
• tetraethyl pyrophosphates
KMD| PHARMACOLOGY 2016
• used as insectides FUNCTIONAL ANTAGONISM
à Organophosphates — also known as “physiologic antagonism”
à Carbamates ex: Epinephrine (tx for anaphylaxis)
• synthesized nerve gas
• responsible of cholinesterase
CHEMICAL ANTAGONISM
— prevents the actions of an agonist by modifying or
THERAPEUTIC USE OF ANTICHOLINESTERASE sequestering the agonist so that it is incapable of binding to &
activating its receptor
ex: Dimercaprol (chelator of Lead)
Lipstick contains Lead (“Cumulative Poisoning”)
Pb binds to specific receptor
Dimercaprol will bind with Lead = complex (neutralized lead)
Heavy Metals: Pb (Lead), Hg (Mercury), Cd (Cadmium) ß used to find
them in batteries
Elements in metallic nature: Iron, Magnesium, Manganese, Silver,
Copper, Gold, Iron, Aluminum
Milk natural chelator of gold
DURATION OF DRUG ACTION
— the effect lasts only as long as the drug occupies the receptor &
dissociation of drug from the receptor automatically
terminates the effect
*Edrophonium is only a diagnostic agent for Myasthenia Gravis. *Teacher’s explanation*
§ it is determined by how long your drug receptor
PHARMACOLOGIC ACTION complex stays in place
• cholinesterase inhibits production of muscarinic effect § how long a drug & a receptor are bound together
• direct-acting cholinergic agonists will determine how long drug effect will last
• cause hypotensive response § if they stay together the pharmacological effect lasts
• anticholinergic poisoning à ataxia, confusion, respiratory longer but if they stay for a very short time the
abnormalities, convulsions, coma & death by respiratory pharmacological effect will be only for a very short
paralysis time
— ex: Paracetamol (taken up every 4hrs ß the duration of action
ADVERSE EFFECTS is only 4hrs)
• inability to accommodate for vision
• severe rhinorrhea, severe headache RECEPTORS & INERT BINDING SITES
• severe SLUD à salivation, lacrimation, urination, defecation (Criteria for a drug & a receptor to bind together)
• fatigue & general weakness — to function as a receptor, an endogenous molecule must:
• muscle twitching, fasciculations, muscle cramps 1. It has to be selective in choosing ligands (drug molecule) to
• over exposed to anticholinesterases à exaggerated bind
parasympathetic effects 2. It must change its function upon binding in such a way that the
function of the biologic system is altered
THERAPEUTIC EFFECTS
• Glaucoma PHARMACOKINETICS (What the body does to the drug)
• Xerostomia
• Reversal of neuromuscular blockage
• myasthenia gravis Absorption
• atropine poisoning Distribution
• paralytic ileus Metabolism
• bladder atony Excretion
• senile dementia (Alzheimer’s disease)
Definition:
1. Permeation – movement of a drug molecule into & within the
COMPETITVE ANTAGONIST biologic environment
2. Prodrug – precursor chemical that is readily absorbed &
— if both the antagonist & the agonist bind to the same site on the distributed the converted to active drug by biologic processes
receptor, they are said to be “competitive” 3. Free Drug – exerts biologic effect
— competitive antagonist will prevent an agonist from binding to 4. Bound Drug – stay in the vascular space & is not metabolized
its receptor & maintain the receptor & maintain the receptor in or eliminated
its inactive conformational state 5. Bioavailability – is the fraction of administered drug that
ex: Beta blocker reaches the systemic circulation
Antihistamine 6. Half Life – period of time required for the concentration of
a. H1 à blockers; anti-allergies drug to decrease by one-half
b. H2 à gastric secretions
Anaphylaxis à H1 à Histamine (antidote for allergies)
treated by: epinephrine DRUG ABSORPTION
— the movement of the drug from its site of administration into
the blood stream or “systemic circulation”
ADVERSE DRUG REACTIONS
• 5% of adults are allergic to one or more medications
• 6-10% of ADRs result from a drug allergy
• 3% of hospital admission are due to ADRs
• 28% of ADRs are preventable
• drugs associated with ADRs: 29% analgesics, 10% sedatives,
9% antibiotics & 7% antipsychotics
KMD| PHARMACOLOGY 2016
§ Propranolol – bronchial asthma
ADRs: 4th leading cause of death § Tetracycline – hypoplasia of the teeth
Study: Drug reactions kill an estimated 100,000 a year
• April 14, 1998 Examples of Bizarre reactions:
§ Hypersensitivity reactions
ADVERSE DRUG REACTIONS (ADRs) § Stevens-Johnson’s Syndrome
— any response to a drug which is noxious & unintended and § Hemolytic anemia
which occurs at doses used in man for prophylaxis, diagnosis
or therapy • TYPE C (CONTINUOUS)
ADVERSE DRUG EXPERIENCE — long term effects are usually related to the dose &
— an undesirable drug effect, whether harmless, resulting from duration of treatment
medications administered in a dosage normally given Examples: Ethambutol (causes neuritis) & NSAIDs (reduces
— it becomes an adverse drug reaction when it is reported & inflammation & blocks pain)
subsequently evaluated to be secondary to the drug usage
• TYPE D (DELAY)
KEY POINTS TO REMEMBER (ADRs) — Teratogenic (formation of monster/deformities)
• are undesirable — Carcinogenic (formation of cancer cells)
• are unintentional Examples: Thalidomide & Vitamin A (not allowed for
• are suspected (not necessarily proven) pregnant women because it will cause birth defects)
• may develop as a consequence of therapy for other procedures
• TYPE E (ENDING OF USE)
*The WHO definition of ADR does not necessarily include: — withdrawal syndromes
à drugs administered or taken in error Examples:
à drugs given by erroneous method § Benzodiazepines – rebound insomnia, agitattion
§ Clonidine – rebound hypertension
FACTORS AFFECTING ADVERSE DRUG REACTIONS: § Corticosteroids – acute adrenal insuffiency
• Patient-related factors § Opioids – narcotic withdrawal
— age
— sex • TYPE F (FAILURE OF EFFICACY)
— genetic influences — Counterfeit medicines
— concurrent diseases (renal, liver, cardiac) — Underdosing of medications
— previous adverse drug reactions — Drug Interactions
— compliance with dosing regimen
— total number of medications WHY REPORT ADRs?
— misc (diet, smoking, environmental exposure) — To prevent drug-induced human suffering
— To avoid financial risks associated with unexpected risks
• Drug-related factors
— dose IMPORTANT:
— duration • The ADR Report form should include the following:
— inherent toxicity of the agent — the brand name of the suspect drug
— pharmacodynamics properties — the manufacturer (if generic)
— pharmacokinetic properties — the lot and batch number
— it should be done in duplicate
SIX CLASSIFICATIONS OF ADR — all reports are confidential
• TYPE A (AUGMENTED)
TEN COMMNANDMENTS TO REDUCE ADRs:
Extension effects: I. Critically review the total condition of the patient. Be
— predictable particularly careful when you prescribe to children,
— dose-related responses elderly, seriously ill, pregnant patients & those with renal,
— prevention: Adjustment of dosage regimen cardiac or lover diseases
Examples: II. Use as few drugs as possible. Balance the seriousness of
§ Benzodiazepines – sedation possible reactions against the beneficial effects of each
§ Furosemide – water & electrolyte imbalance drug that is being considered
§ Heparin, warfarin – spontaneous bleeding III. Know well the drugs that you use. Compare efficacy &
§ Insulin – hypoglycemia safety of each of the available competitive medications
that appear to be worthy of consideration for the patient.
• TYPE B (BIZARRE) IV. Do not change too readily from one drug you know to one
— abnormal effects, unrelated from the drug’s you do not know. If you decide to use a new drug, know
unknown pharmacological actions that drug.
— characteristics: V. Do not hesitate to use textbooks & other references
§ no formal dose-response curve (penicillin providing information on drug reaction & interaction.
hypersensitivity – anaphylaxis) VI. Be especially careful when prescribing drugs known to
§ reaction disappears on discontinuation of exhibit a large variety of reactions/interactions.
the drug VII. Be aware of interactions with certain foods, alcohol &
§ recognizable as an immunological even with household chemicals
reaction VIII. Regularly make an inventory of the drugs.
§ undetectable during conventional testing IX. Review your patient regularly for all the drug used &
§ little or no relation to the usual especially those bought without prescriptions.
pharmacological effects of the drug X. If your patient shows signs & symptoms not clearly
Examples: explained by the course of illness, think of adverse drug
§ INH, Rifampicin, PZA – hepatoxicity reaction.
§ Streptomycin – ototoxicity, nephrotoxicity
§ Captopril – cough DRUG INTERACTIONS
§ Simvastatin – rhabdomyolysis — a reaction that occurs when two drugs are taken
§ Nitrates – headache simultaneously
— Types: Pharmacokinetic & Pharmacodynamic interactions
KMD| PHARMACOLOGY 2016
MARILYN MONROE 3 MAJORS MANIFESTATIONS OF INFLAMMATION:
§ Chloral Hydrate • Rubor (Redness)
§ Pentobarbital (sedative) • Calor (Heat)
JIMI HENDRIX • Tumor (Swelling)
§ Brallobarbital Sedatives, Anticonvulsants • Dolor (Pain)
§ Secobarbital • Loss of function/disturbance of function
§ Hydroxyzine (Anti-allergy)
BRUCE LEE After a person is injured, chemical substances called Mediators of
§ Meprobamate (NSAIDs) inflammation:
§ Aspirin 1. Histamine
ELVIS PRESLY 2. Kinins
§ Methaqualone 3. PG’s (Prostaglandins)
§ Codeine 4. Leukotrienes (LT)
§ Barbiturates
§ Cocaine • Some mediators induce dilation of blood vessels & produce the
KURT COBAINE symptoms of redness & heat
§ Heroin • Also stimulate pain receptors & increase the permeability of
§ Diazepam (sedative-hypnotic) blood vessels (Nociception)
EDDIE GUERRERO • Sometimes the inflammatory response last longer or is more
§ anabolic steroids (stanozolol, HCG) intense then is desirable & drugs are used to suppress the
CHRIS BENOIT symptoms
§ Alprazolam
§ Hydrocodone 1. Antihistamines – blocks the effect of histamine
§ Hydromorphone 2. Aspirin – prevents the synthesis of PG’s; prototype all NSAIDs,
GEORGE BEST analgesic & antipyretic activity
§ Ethanol 3. Cortisone – reduces the release of several mediators of
HEATH LEDGER inflammation
§ Oxycodone - corticosteroids is capable of retaining water
§ Hydrocodone resulting edema
§ Alprazolam side effects: immunocompromizatio of the
§ Diazepam immune system/lowering of the immune
§ Temazepam system & capable of retaining water therefore
§ Doxylamine causing edema
MICHAEL JACKSON
§ Propofol (anesthetic drug) *HISTAMINE à a neurotransmitter that would cause bronchoconstriction
§ Midazolam
§ Lidocaine • IMMUNE RESPONSE occurs when immunologically competent
§ Diazepam
cells are activated in response to foreign organisms or
§ Lorazepam
antigenic substances liberated during the acute or chronic
WHITNEY HOUSTON
inflammatory response
§ Cocaine
• the outcome of the immune response for the host may be
§ Flexeril
beneficial as when it causes invading organisms to be
§ Marijuana
phagocytosed or neutralized
§ Alprazolam
• on the other hand, the outcome may be deleterious if it leads to
§ Diphenhydramine
chronic inflammation without resolution of the underlying
AMY WINEHOUSE
injurious process
§ Ethanol
• Cell damage associated with inflammation acts on cell
PHILIP SEYMOUR HOFFMAN
membrane to cause leukocytes to release lysosomal enzymes:
§ Heroin
arachidonic acid (fatty acids) is the liberated from precursor
§ Cocaine
compounds & various licosanoids are synthesized
§ Benzodiazepine
§ Amphetamine
CORY MONTEITH
§ Heroin
§ Alcohol
*sedative uses: lack of sleep & anxiety issues
NONSTEROIDAL ANTI-INFLAMMATORY
DRUGS
INFLAMMATION/INFLAMMATORY RESPONSE
— occurs when tissues are damaged
AGENTS WHICH CAN CAUSE INJURY:
1. Microorganisms
2. Cold
3. Heat
4. Radiant Energy
5. Chemicals
6. Electricity
KMD| PHARMACOLOGY 2016
— irreversible acetylates & blocks platelet cyclooxygenase, while
most non-COX-seletive NSAIDs are reversible inhibitors
• Selective COX-2 inhibitors do not affect platelet function at
their usual doses
• COX-2 can cause increase CVS thrombotic events
• CELECOXIB has an FDA-initiated “black box” warning
concerning CV risks
• All newer NSAIDs are analgesic, anti-inflammatory & antipyretic
and all (except the COX-2-selective agents & the nonacetylated
salicylates) inhibit platelet aggregation
• NSAIDs are all gastric irritants & can be associated with GI
ulcers & bleeds as well, although newer agents tend to cause less
GI irritation than aspirin
• HEPATOTOXICITY has been observed for all the drugs; Major
issue for NSAIDs
• Several NSAIDs (including aspirin) appear to reduce the induce
of colon cancer when taken chronically
Sir Jace’s explanation: Arachidonic Acid is an essential fatty acid (other two *COX-2 is safe to take when you do not eat food while NONSPECIFIC
fatty acids needed for homeostasiss: Linolenic & Linoleic Acid). Arachidonic NSAIDs are not safe to be taken without food
Acid is the precursor for the production of PG’s. COX2 is responsible for pain
& inflammation while COX-1 is responsible for kidney, GI tract, brain, COMMON ADVERSE DRUG REACTIONS:
nausea, vascular tone & pain. COX-2 is for pain & inflammation while 1. CNS: headache, tinnitus & dizziness
COX-1 is for homeostasis 2. CV: fluid retention, HTN, edema, rarely CHF
3. GI: abdominal pain, dysplasia, N/V & rarely ulcers or bleeding
linolenic & linoleic acid à obtained from coconut oil 4. HEMATOLOGIC: rare thrombocytopenia, neutropenia or
arachidonic acid à obtained from peanuts aplastic anemia
à precursor for production of PGs 5. HEPATIC: abnormal liver function tests & rare liver failure,
Cyclooxygenase à produce PGs 6. PULMONARY: asthma
Lipoxygenase enzyme à yields leukotrienes 7. RASHES: all types, pruritus
8. RENAL: renal insufficiency, renal failure, hyperkalemia &
Treatment of patients with inflammation involve two primary goals: proteinuria
A. The relief of symptoms & the maintenance of function
B. The slowing or arrest of the tissue-damaging process *TINNITUS à ringing of your ears
GLUCOCORTICOIDS • with higher doses, may experience:
— have powerful anti-inflammatory effects & when 1st introduced SALICYLISM: vomiting, tinnitus, decreased hearing, vertigo
were considered to be the ultimate answer to the treatment of salicylic acid à aspirin (rarely used as an anti-inflammatory
inflammatory arthritis medication)
DMARDs (Disease-modifying antirheumatic drugs) *SALICYLISM caused by over dosage & reversible
— agents used to treat rheumatoid arthritis
— they decreases inflammation, usually improve symptoms & MECHANISM OF ACTION
slow the bone damage associated with rheumatoid arthritis 1. Anti-inflammatory effects
1. Late-onset — non-selective inhibitor of both COX isoforms
2. Early-onset (Juvenile Arthritis) — aspirin irreversible inhibits COX & inhibits platelet
aggregation
*first line of drug used for arthritic conditions: ACETAMINOPHEN 2. Analgesic effects
(PARACETAMOL) — aspirin is most effective in reducing mild to
moderate pain
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
— other similar agents used to treat rheumatic disease suppress CLINICAL USES
the signs & symptoms of inflammation • antipyresis, anti-inflammatory effects
— these drugs also exert antipyretic & analgesic effects, but is — decreases the incidence of TIA, unstable angina,
their anti-inflammatory properties that make them most useful coronary artery thrombosis with MI, thrombosis
after coronary artery bypass grafting
1st drug used for arthritic conditions à ACETAMINOPHEN — long-term use at low dosage is associated with lower
incidence of colon cancer
NABUMETONE à a ketone prodrug
• all NSAIDs are weak acids except NABUMETONE NONACETYLATED SALICYLATES
— magnesium choline salicylates, sodium salicylate & salicyl
salicylate
NSAIDs is mediated chiefly through inhibition of biosynthesis of PGs — all nonacetylated salicylates are effective anti-inflammatory
• additional possible mechanisms of action: drugs, although they may be less effective than analgesics than
1. Inhibition of chemotaxis aspirin
2. Down-regulation of interleukin-1 pro
3. Decreases production of free radicals • CELECOXIB
4. Superoxides • ETORICOXIB
5. Interference with calcium-mediated intracellular events — bipyridine derivative
— 2nd generation COX-2 selective inhibitor with the
highest selectively ratio of any coxib for inhibition of
ASPIRIN COX-2
— prototype — extensively metabolized by hepatic P450 enzymes
— elimination half-life of 22 hours
PRESCRIPTION DRUG
PRESCRIPTION ERRORS: — drug that requires a prescription because it is considered
1. Erroneous Prescriptions potentially harm if not used under the supervision of a licenses
: Brand name before generic health care practitioner
: Generic in parenthesis — known synonymously as a legend drug because the label of the
: Brand name no parenthesis drug bears the legeng, “Caution: Federal Law Prohibits
2. Violative Prescriptions Dispensing without a prescription” or “Rx only”
: Generic name not written ETHICAL/LEGEND DRUGS
: Generic not legible & brand is legible — Antibiotics: prescription drugs requiring ordinary
: Instruction with “no substitution” prescription
Violation of R.A 6675 — Exempt preparations requiring ordinary prescription with
3. Impossible Prescriptions prescriber’s S2 # (EDD, Rx)
: Generic name is written but not legible — Dangerous drugs requiring yellow prescription in triplicate
: Generic name does not correspond to the brand (DD, Rx) à demerol
name
: Generic name & brand name not legible CONTROLLED/SCHEDULED DRUG
: Drug product prescribed is not registered with PDA — A prescription drug whose use & distribution is tightly
controlled because of its abuse potential or risk
— are classified into schedules
— prescription for controlled substances have additional
requirements by law & these includes the:
a. Potential for abuse
b. Pharmacological effects
c. Risk to public health
d. History, cope, duration & significance of the abuse &
potential for psychic or physiological dependence
A. SCHEDULE I
— drugs have high potential for abuse
— not accepted medical use in the US
— 3 categories of substances: OPIATES, OPIUM
DERIVATIVES & HALLUCINOGENS
— Properly registered persons may use schedule I
substance for research purposes
— Other examples: Heroin, marijuana, peyote,
mescaline, psilobycin, THC, Dihydromorphine, LSD
B. SCHEDULE II
— drugs have high potential for abuse
— not accepted medical use in the US
— it has been determine that the abuse of a drug, or
other substances include in this schedule à
psychological or physical dependence
— categories: OPIATES, OPIUM DERIVATIVES,
DERIVATIVE OF COCA LEAVES & CERTAINE CNS
STIMULANTS & DEPRESSANTS
— Examples: Narcotic substances (Opium, morphine,
codeine, hydromorphone, methadone,
oxycodone+ASA, anileridine, oxymorphone, pantopon,
meperidine, cocaine, Amphetamine,
methamphetamine, phenmetrazine, methylphenidate,
KMD| PHARMACOLOGY 2016
amobarbital, pentobarbital, secobarbital, etorphine TYPES OF INCORRECT PRESCRIPTION
HC, diphenoxylate & phencyclidine 1. Erroneous
C. SCHEDULE III • The brand name precedes the generic name
— drugs have medical use & have a lower potential • The generic name is the one in parenthesis
for abuse than Schedule I & II • The brand name is not parenthesis
— includes compounds containing limited quantities of 2. Impossible
certain narcotic drugs & nonnarcotic drugs such as: • only the generic name is written but is not legible
Derivatives of barbituric acid except Schedule II, • the generic name does not corresponds to the brand
Glutethimide, methprylon, nalorphine, name
benzphetamine, chlorphentermine, clortermine, • both the generic name & the brand name are not
phendimetrazine, paregoric legible
D. SCHEDULE IV 3. Violative
— drugs have low potential for abuse relative to those • The generic name is not written
in schedule III • The generic name is not legible & a brand name that
— Abuse of schedule IV may lead to limited physical is legible is written
dependence or psychological dependence as • The brand name is indicated & instructions added
compared to those included in schedule III
(such as the phrase “NO SUBSTITUTION”) that tend to
— generally the long-acting barbiturates, certain
obstruct, hinder or prevent generic dispensing
hypnotics, minor tranquilizers
— practical purposes: NO REGULATORY DIFFERENCES
BETWEEN SCHED III & IV
— examples: Barbital, Phenobarbital,
Methyphenobarbital, Chloral betaine, Chloral
hydrate, Ethchlorvynol, Ethinamate,
Meprobamate, Paraldehyde, Methohexital,
Fenfluramine, Diethylpropion, Phentermine,
Chlordiazepoxide, Diazepam, Oxazepam,
Clorazepate, Flurazepam, Clonazepam, Prazepam,
Lorazepam, Mebutamate, Propoxyphene,
Pentazocine
E. SCHEDULE V
— drugs have the lowest abuse potential of the
controlled substances
— consist of preparations containing limited quantities
of certain narcotic drugs generally for antitussive &
antidiarrheal purposes
— OTC drugs
— Nonnarcotic substances that may be sold OTC under
the terms of the FD&C may apply to the DEA to have
their product excluded from any schedule
§ Phenobarbital à common substance
LIST OF OTC MEDICINES
• Anti-haemorrhoids
Cough-suppresants
•
• Anti-acne drugs
• NSAIDs
• Antiseptics
• Analgesics
• Decongestants
• Aspirin
• Vasodilators
• Antacids
• Expectorants (Available w/o physician’s Rx)
• Antihistamines (Available w/o physician’s Rx)
• Anti-gas agents
CONTROLLED SUBSTANCE
• all Rx must be written in ink; this practice is compulsory for
Schedule II drugs
• date
• prescriber’s name & address
• patient’s name, age & address
• diagnosis
• no abbreviations
• all doses, number of ampules, tablets, etc should be written in
words (letters) and in figures (numbers)
• prescriber’s signature
• prescription is dispensed once & kept by pharmacist
REFILL
• For schedule II drugs à NO REFILL
• For schedule III & IV drugs à not exceed 5 refills or 6 months
after the issue date
• For schedule V drugs à no restriction
KMD| PHARMACOLOGY 2016